274 related articles for article (PubMed ID: 27760304)
21. Phosphatidylinositol 3-kinase.
Kapeller R; Cantley LC
Bioessays; 1994 Aug; 16(8):565-76. PubMed ID: 8086005
[TBL] [Abstract][Full Text] [Related]
22. Oligodendrocyte differentiation and signaling after transferrin internalization: a mechanism of action.
Pérez MJ; Fernandez N; Pasquini JM
Exp Neurol; 2013 Oct; 248():262-74. PubMed ID: 23797152
[TBL] [Abstract][Full Text] [Related]
23. PI3K/Akt signalling pathway and cancer.
Fresno Vara JA; Casado E; de Castro J; Cejas P; Belda-Iniesta C; González-Barón M
Cancer Treat Rev; 2004 Apr; 30(2):193-204. PubMed ID: 15023437
[TBL] [Abstract][Full Text] [Related]
24. Depolarization increases phosphatidylinositol (PI) 4,5-bisphosphate level and KCNQ currents through PI 4-kinase mechanisms.
Zhang X; Chen X; Jia C; Geng X; Du X; Zhang H
J Biol Chem; 2010 Mar; 285(13):9402-9409. PubMed ID: 20106968
[TBL] [Abstract][Full Text] [Related]
25. Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K.
Yudushkin I
Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781447
[TBL] [Abstract][Full Text] [Related]
26. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
Nozhat Z; Hedayati M
Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
[TBL] [Abstract][Full Text] [Related]
27. Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis.
Martelli AM; Cocco L; Capitani S; Miscia S; Papa S; Manzoli FA
Eur J Histochem; 2007; 51 Suppl 1():125-31. PubMed ID: 17703603
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Akt signaling by exclusion from lipid rafts in normal and transformed epidermal keratinocytes.
Calay D; Vind-Kezunovic D; Frankart A; Lambert S; Poumay Y; Gniadecki R
J Invest Dermatol; 2010 Apr; 130(4):1136-45. PubMed ID: 20054340
[TBL] [Abstract][Full Text] [Related]
29. The phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin signaling network and the control of normal myelopoiesis.
Martelli AM; Chiarini F; Evangelisti C; Grimaldi C; Ognibene A; Manzoli L; Billi AM; McCubrey JA
Histol Histopathol; 2010 May; 25(5):669-80. PubMed ID: 20238304
[TBL] [Abstract][Full Text] [Related]
30. Thrombopoietin induces activation of the phosphatidylinositol-3' kinase pathway and formation of a complex containing p85PI3K and the protooncoprotein p120CBL.
Sattler M; Salgia R; Durstin MA; Prasad KV; Griffin JD
J Cell Physiol; 1997 Apr; 171(1):28-33. PubMed ID: 9119889
[TBL] [Abstract][Full Text] [Related]
31. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation.
Toulany M; Rodemann HP
Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967
[TBL] [Abstract][Full Text] [Related]
32. Critical role for lipid raft-associated Src kinases in activation of PI3K-Akt signalling.
Arcaro A; Aubert M; Espinosa del Hierro ME; Khanzada UK; Angelidou S; Tetley TD; Bittermann AG; Frame MC; Seckl MJ
Cell Signal; 2007 May; 19(5):1081-92. PubMed ID: 17275257
[TBL] [Abstract][Full Text] [Related]
33. Roles of glucose transporter-1 and the phosphatidylinositol 3‑kinase/protein kinase B pathway in cancer radioresistance (review).
Fang J; Zhou SH; Fan J; Yan SX
Mol Med Rep; 2015 Mar; 11(3):1573-81. PubMed ID: 25376370
[TBL] [Abstract][Full Text] [Related]
34. PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice is involved in the rapid onset antidepressant-like effects of GLYX-13.
Lu Y; Wang C; Xue Z; Li C; Zhang J; Zhao X; Liu A; Wang Q; Zhou W
Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25542689
[TBL] [Abstract][Full Text] [Related]
35. The essential role of phosphoinositide 3-kinases (PI3Ks) in regulating pro-inflammatory responses and the progression of cancer.
Chen K; Iribarren P; Gong W; Wang JM
Cell Mol Immunol; 2005 Aug; 2(4):241-52. PubMed ID: 16274621
[TBL] [Abstract][Full Text] [Related]
36. PI3K isoforms in cell signalling and vesicle trafficking.
Bilanges B; Posor Y; Vanhaesebroeck B
Nat Rev Mol Cell Biol; 2019 Sep; 20(9):515-534. PubMed ID: 31110302
[TBL] [Abstract][Full Text] [Related]
37. Phosphatidylinositide 3-kinase/AKT in radiation responses.
Zhan M; Han ZC
Histol Histopathol; 2004 Jul; 19(3):915-23. PubMed ID: 15168354
[TBL] [Abstract][Full Text] [Related]
38. [Genetic alterations in MAPK and PI3K/Akt signaling pathways and the generation, progression, diagnosis and therapy of thyroid cancer].
Liu B; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Dec; 29(6):1221-5. PubMed ID: 23469561
[TBL] [Abstract][Full Text] [Related]
39. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
Chi H
Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
[TBL] [Abstract][Full Text] [Related]
40. Molecular determinants and feedback circuits regulating type 2 CRH receptor signal integration.
Markovic D; Punn A; Lehnert H; Grammatopoulos DK
Biochim Biophys Acta; 2011 May; 1813(5):896-907. PubMed ID: 21338628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
